Lexeo Therapeutics, Inc. Common Stock
Veridion Score
Composite trend over time
Why is LXEO moving today?
Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for LXEO.
LXEO insider activity
Lexeo Therapeutics, Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Net selling: -$678K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-07 | 2026-04-06 | Townsend Richard Nolan | Insider | sell | $5.69 | 55,000 | 340,106 | $313K | SEC Form 4 |
| 2026-03-17 | 2026-03-13 | Otero Jose Manuel | Insider | buy | $2.64 | 5,930 | 131,390 | $16K | SEC Form 4 |
| 2026-03-17 | 2026-03-13 | Townsend Richard Nolan | Insider | buy | $2.64 | 2,623 | 395,106 | $7K | SEC Form 4 |
| 2026-02-20 | 2026-02-18 | Otero Jose Manuel | Insider | sell | $6.40 | 3,016 | 125,460 | $19K | SEC Form 4 |
| 2026-02-20 | 2026-02-18 | Townsend Richard Nolan | Insider | sell | $6.38 | 10,173 | 392,483 | $65K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 23 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moLXEO contract awards, year to date.
Public federal awards linked to this ticker.
LXEO lobbying filings, year to date.
Registered lobbying filings matched to Lexeo Therapeutics, Inc. Common Stock.